Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.

[1]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[2]  T. Mosmann,et al.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. , 1987, Journal of immunology.

[3]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[4]  R. Locksley,et al.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism , 1990, The Journal of experimental medicine.

[5]  M. Urdea,et al.  Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. , 1991, Nucleic acids symposium series.

[6]  A. Sher,et al.  Regulation and biological function of helminth-induced cytokine responses. , 1991, Immunology today.

[7]  B. Walker,et al.  Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. , 1992, Journal of immunology.

[8]  J. Berzofsky,et al.  Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection , 1992, Immunological reviews.

[9]  G. Davis,et al.  Hepatitis C virus infection in kidney transplant recipients , 1993, Hepatology.

[10]  G. Davis,et al.  Significance of serum hepatitis C virus RNA levels in chronic hepatitis C , 1993, The Lancet.

[11]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.

[12]  L. Stuyver,et al.  Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. , 1993, The Journal of general virology.

[13]  M. Houghton,et al.  T-lymphocyte response to hepatitis C virus in different clinical courses of infection. , 1993, Gastroenterology.

[14]  Y. Yazaki,et al.  HLA B44–restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein , 1993, Hepatology.

[15]  B. Walker,et al.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV , 1993, Journal of virology.

[16]  C. Ferrari,et al.  T‐cell response to structural and nonstructural hepatitis C virus antigens in persistent and self‐limited hepatitis C virus infections , 1994, Hepatology.

[17]  E. Holmes,et al.  A proposed system for the nomenclature of hepatitis C viral genotypes , 1994, Hepatology.

[18]  L. Stuyver,et al.  Analysis of hepatitis C virus genotypes by a line probe assay and correlation with antibody profiles. , 1994, Journal of hepatology.

[19]  J. Lau,et al.  Hepatitis C virus: From epidemiology and molecular virology to immunobiology , 1994, Hepatology.

[20]  A S Perelson,et al.  Th1/Th2 cross regulation. , 1993, Journal of theoretical biology.

[21]  F. Chisari,et al.  Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. , 1995, The Journal of clinical investigation.

[22]  M. de Carli,et al.  Preferential expression of CD30 by human CD4+ T cells producing Th2‐type cytokines , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  B. Irvine,et al.  Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. , 1995, Analytical biochemistry.

[24]  A. Mowat,et al.  Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defence? , 1995, Immunology today.

[25]  T. Kodama,et al.  A helper T‐cell antigen enhances generation of hepatitis C virus‐specific cytotoxic T lymphocytes in vitro , 1995, Journal of medical virology.

[26]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[27]  J. Berzofsky,et al.  Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules , 1995, Journal of virology.

[28]  R. Coffman,et al.  Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. , 1995, Science.

[29]  P. Simmonds,et al.  Implications of variations of "conserved" regions of hepatitis C virus genome , 1995, The Lancet.